Integer Holdings Corp. engages in manufacturing and developing medical devices and components. It operates through Medical and Non-Medical segments. The Medical segment include cardio and vascular; cardiac and neuromodulation; and advanced surgical, orthopedics, and portable medical. The Non-Medical segment focuses on lithium cells, and primary and secondary battery packs for applications in the energy, military and environmental markets.The company was founded by Wilson Greatbatch in 1970 and is headquartered in Frisco, TX.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNYSE:ITGR
Previous SymbolNASDAQ:ITGR
CUSIP39153L10
Phone214-618-5243
Debt
Debt-to-Equity Ratio0.88
Current Ratio2.41
Quick Ratio1.32
Price-To-Earnings
Trailing P/E Ratio29.44
Forward P/E Ratio22.68
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.46 billion
Price / Sales1.84
Cash Flow$6.3812 per share
Price / Cash Flow13.01
Book Value$28.21 per share
Price / Book2.94
Profitability
EPS (Most Recent Fiscal Year)$2.81
Net Income$66.67 million
Net Margins14.12%
Return on Equity12.78%
Return on Assets4.44%
Miscellaneous
Employees9,700
Outstanding Shares32,380,000
Market Cap$2.71 billion
OptionableOptionable
Integer (NYSE:ITGR) Frequently Asked Questions
What is Integer's stock symbol?
Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."
How were Integer's earnings last quarter?
Integer Holdings Corp (NYSE:ITGR) posted its earnings results on Thursday, November, 1st. The medical equipment provider reported $1.06 EPS for the quarter, beating the Zacks' consensus estimate of $0.92 by $0.14. The medical equipment provider earned $305.10 million during the quarter, compared to analysts' expectations of $301.95 million. Integer had a net margin of 14.12% and a return on equity of 12.78%. Integer's revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.91 earnings per share. View Integer's Earnings History.
When is Integer's next earnings date?
What guidance has Integer issued on next quarter's earnings?
Integer issued an update on its FY18 earnings guidance on Thursday, November, 1st. The company provided earnings per share (EPS) guidance of $3.55-3.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.59. The company issued revenue guidance of $1197-1212 million, compared to the consensus revenue estimate of $1.28 billion.
What price target have analysts set for ITGR?
4 brokerages have issued 12-month price objectives for Integer's stock. Their forecasts range from $78.00 to $93.00. On average, they anticipate Integer's share price to reach $84.50 in the next year. This suggests a possible upside of 1.8% from the stock's current price. View Analyst Price Targets for Integer.
What is the consensus analysts' recommendation for Integer?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Integer.
Has Integer been receiving favorable news coverage?
News articles about ITGR stock have trended very positive on Monday, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Integer earned a coverage optimism score of 3.9 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of Integer's key competitors?
Some companies that are related to Integer include CAE (CAE), Energizer (ENR), Spectrum Brands (SPB), Novanta (NOVT), Electro Scientific Industries (ESIO), Atkore International Group (ATKR), Ultralife (ULBI), Maxwell Technologies (MXWL), Flux Power (FLUX), Arotech (ARTX), FuelCell Energy (FCEL), Polar Power (POLA), Sono-Tek (SOTK), Highpower International (HPJ) and CBAK Energy Technology (CBAK).
Who are Integer's key executives?
Integer's management team includes the folowing people:
- Joseph W. Dziedzic, President, Chief Executive Officer & Director
- Jason Garland, Chief Financial Officer & Executive Vice President
- Michael Spencer, Senior VP, Chief Ethics & Compliance Officer
- Jeremy A. Friedman, Executive Vice President
- Kirk Thor, Chief Human Resources Officer & Executive VP
Who are Integer's major shareholders?
Integer's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.73%), Vanguard Group Inc. (10.12%), Dimensional Fund Advisors LP (7.80%), LSV Asset Management (2.29%), JPMorgan Chase & Co. (2.21%) and JPMorgan Chase & Co. (2.19%). Company insiders that own Integer stock include Bill R Sanford, Declan Smyth, Gary J Haire, Jennifer M Bolt, Jeremy Friedman, John A Harris, Jose Antonio Gonzalez, Joseph F Flanagan, Joseph W Dziedzic, Kristin Trecker, Michael L Spencer, Pamela G Bailey, Peter H Soderberg, Thomas J Hook, Thomas J Mazza, Timothy G Mcevoy and William B Summers Jr. View Institutional Ownership Trends for Integer.
Which institutional investors are selling Integer stock?
ITGR stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Wells Fargo & Company MN, Point72 Asset Management L.P., Dimensional Fund Advisors LP, William Blair Investment Management LLC, Franklin Resources Inc., Hsbc Holdings PLC and Smith Graham & Co. Investment Advisors LP. Company insiders that have sold Integer company stock in the last year include Bill R Sanford, Declan Smyth, Gary J Haire, Jennifer M Bolt, Jeremy Friedman, Jose Antonio Gonzalez, Joseph F Flanagan, Joseph W Dziedzic, Michael L Spencer, Pamela G Bailey, Peter H Soderberg, Thomas J Mazza, Timothy G Mcevoy and William B Summers Jr. View Insider Buying and Selling for Integer.
Which institutional investors are buying Integer stock?
ITGR stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., Matarin Capital Management LLC, Castleark Management LLC, Renaissance Technologies LLC, Vanguard Group Inc., Deutsche Bank AG and Assenagon Asset Management S.A.. View Insider Buying and Selling for Integer.
How do I buy shares of Integer?
Shares of ITGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Integer's stock price today?
One share of ITGR stock can currently be purchased for approximately $83.02.
How big of a company is Integer?
Integer has a market capitalization of $2.71 billion and generates $1.46 billion in revenue each year. The medical equipment provider earns $66.67 million in net income (profit) each year or $2.81 on an earnings per share basis. Integer employs 9,700 workers across the globe.
What is Integer's official website?
How can I contact Integer?
Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider can be reached via phone at 214-618-5243 or via email at [email protected]
MarketBeat Community Rating for Integer (NYSE ITGR)
MarketBeat's community ratings are surveys of what our community members think about Integer and other stocks. Vote "Outperform" if you believe ITGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ITGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
